- Home
- RKDA vs CNSP Comparison
RKDA vs CNSP Comparison
Compare RKDA & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKDA
- CNSP
- Stock Information
- Founded
- RKDA 2002
- CNSP 2017
- Country
- RKDA United States
- CNSP United States
- Employees
- RKDA N/A
- CNSP N/A
- Industry
- RKDA Agricultural Chemicals
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- RKDA Industrials
- CNSP Health Care
- Exchange
- RKDA Nasdaq
- CNSP Nasdaq
- Market Cap
- RKDA 5.3M
- CNSP 5.6M
- IPO Year
- RKDA 2015
- CNSP 2019
- Fundamental
- Price
- RKDA $4.71
- CNSP $1.02
- Analyst Decision
- RKDA Strong Buy
- CNSP Hold
- Analyst Count
- RKDA 1
- CNSP 1
- Target Price
- RKDA $6.00
- CNSP N/A
- AVG Volume (30 Days)
- RKDA 14.1K
- CNSP 4.9M
- Earning Date
- RKDA 05-08-2025
- CNSP 05-16-2025
- Dividend Yield
- RKDA N/A
- CNSP N/A
- EPS Growth
- RKDA N/A
- CNSP N/A
- EPS
- RKDA N/A
- CNSP N/A
- Revenue
- RKDA $5,258,000.00
- CNSP N/A
- Revenue This Year
- RKDA $29.40
- CNSP N/A
- Revenue Next Year
- RKDA $25.00
- CNSP N/A
- P/E Ratio
- RKDA N/A
- CNSP N/A
- Revenue Growth
- RKDA 24.92
- CNSP N/A
- 52 Week Low
- RKDA $2.40
- CNSP $0.77
- 52 Week High
- RKDA $10.31
- CNSP $620.00
- Technical
- Relative Strength Index (RSI)
- RKDA 68.36
- CNSP 38.74
- Support Level
- RKDA $3.96
- CNSP $1.04
- Resistance Level
- RKDA $4.79
- CNSP $1.38
- Average True Range (ATR)
- RKDA 0.29
- CNSP 0.22
- MACD
- RKDA 0.05
- CNSP 0.00
- Stochastic Oscillator
- RKDA 86.09
- CNSP 0.00
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.